Chiesi Group announces mid-year turnover of €1,497 millionSubstantial growth of each of Chiesi’s business areasEurope remains the biggest market, followed…
LINCOLN, Neb., Aug. 08, 2023 (GLOBE NEWSWIRE) -- NRC Health, a leading provider of Human Understanding® and data-driven insights, is…
– Second quarter revenue of $12.4M, +53% year-over-year growth– Second quarter pulse recurring revenue of $3.3M, +100% year-over-year growth– First…
Results from Phase 1b/2 trial showed complete responses achieved and ongoing durable responses observed out to approximately 36 months across…
Virtue® Sirolimus AngioInfusion Balloon (“SAB”) is the only non-coated angioplasty system providing protected delivery of extended release sirolimus under clinical…
BOCA RATON, Fla., Aug. 08, 2023 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in…
– Interim data readouts from ongoing Phase 1/2 trials of INZ-701 in adults with ENPP1 Deficiency and ABCC6 Deficiency expected…
Dr. Moll, known as the ‘father of robotic surgery’, is the founder of Intuitive Surgical and creator of the da…
– Phase 2 open-label CONNECT1-EDO51 study open in Canada – – Potentially registrational, randomized, double-blind, placebo-controlled Phase 2 CONNECT2-EDO51 multinational…
AssureCare’s latest product, OptimAIzer, delivers on efficiency, efficacy, and satisfaction for payors, providers, and patientsCINCINNATI, Aug. 08, 2023 (GLOBE NEWSWIRE)…